ZA200903125B - Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs - Google Patents

Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Info

Publication number
ZA200903125B
ZA200903125B ZA200903125A ZA200903125A ZA200903125B ZA 200903125 B ZA200903125 B ZA 200903125B ZA 200903125 A ZA200903125 A ZA 200903125A ZA 200903125 A ZA200903125 A ZA 200903125A ZA 200903125 B ZA200903125 B ZA 200903125B
Authority
ZA
South Africa
Prior art keywords
self
application
cancer drugs
nanoparticles composed
specific intra
Prior art date
Application number
ZA200903125A
Other languages
English (en)
Inventor
Nadya I Tarasova
Sergey G Tarasov
Christopher J Michejda
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Publication of ZA200903125B publication Critical patent/ZA200903125B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200903125A 2006-11-07 2009-05-06 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs ZA200903125B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86466506P 2006-11-07 2006-11-07

Publications (1)

Publication Number Publication Date
ZA200903125B true ZA200903125B (en) 2010-05-26

Family

ID=39365311

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903125A ZA200903125B (en) 2006-11-07 2009-05-06 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Country Status (9)

Country Link
US (1) US9326950B2 (enExample)
EP (1) EP2086521A2 (enExample)
JP (1) JP2010509241A (enExample)
CN (1) CN101610759A (enExample)
AU (1) AU2007316416A1 (enExample)
CA (1) CA2668638A1 (enExample)
NZ (1) NZ576769A (enExample)
WO (1) WO2008058125A2 (enExample)
ZA (1) ZA200903125B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用
WO2012162628A2 (en) 2011-05-25 2012-11-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lipopeptide inhibitors of ras oncoproteins
US9180203B2 (en) 2012-10-23 2015-11-10 The Johns Hopkins University Self-assembling drug amphiphiles and methods for synthesis and use
ES2625024B1 (es) * 2015-12-18 2018-05-10 Consejo Superior De Investigaciones Cientificas Material que comprende tectómeros de oligoglicina y nanohilos
WO2017173398A1 (en) 2016-04-01 2017-10-05 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
WO2019018572A1 (en) * 2017-07-18 2019-01-24 Duke University COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLY PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION
WO2026018050A1 (en) 2024-07-14 2026-01-22 Zare Zardini Hadi Pistacia-derived bioactive peptides encapsulated in soy protein nanoparticles as an anticancer drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT892801E (pt) 1996-04-12 2002-06-28 Us Gov Health & Human Serv Compostos derivados de acridona uteis como agentes antineoplasicos e antiretrovirais
US7105488B1 (en) 1998-02-27 2006-09-12 The United States Of America As Represented By The Department Of Health And Human Services G protein-coupled receptor antagonists
CA2321962C (en) 1998-02-27 2014-07-15 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services G protein-coupled receptor antagonists
US7517849B1 (en) * 1999-11-18 2009-04-14 The United States Of America As Represented By The Secretary Of Health And Human Services Inhibition of ABC transporters by transmembrane domain analogs
AU2001240054B2 (en) 2000-03-07 2005-08-11 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 1,8-Naphthalimide Imidazo[4,5,1-de]acridones with Anti-Tumor Activity
CN1981873A (zh) * 2000-06-09 2007-06-20 莱古伦公司 制备微胶粒的方法和所述微胶粒的用途
WO2002062823A2 (en) * 2001-02-02 2002-08-15 Yale University Peptides for facilitating composite receptor expression and translocation of macromolecules
WO2006010083A2 (en) * 2004-07-08 2006-01-26 Molecular Therapeutics, Inc. Biodegradable nanoparticles
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用

Also Published As

Publication number Publication date
JP2010509241A (ja) 2010-03-25
CN101610759A (zh) 2009-12-23
NZ576769A (en) 2012-01-12
WO2008058125A3 (en) 2008-10-16
CA2668638A1 (en) 2008-05-15
AU2007316416A1 (en) 2008-05-15
EP2086521A2 (en) 2009-08-12
US20100034896A1 (en) 2010-02-11
WO2008058125A2 (en) 2008-05-15
US9326950B2 (en) 2016-05-03

Similar Documents

Publication Publication Date Title
EP2464224A4 (en) METHOD FOR THE ADMINISTRATIVE ADMINISTRATION WITH UNFOLDED AND FOLDED PROTEINS AND PEPTID NANOPARTICLES
IL192869A0 (en) Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
IL200857A (en) Tubolysin conjugates to transfer ligand-associated drugs
EP1833470A4 (en) NANOPARTICLES FOR PROTEIN SUBSTANCE DELIVERY
IL210883A0 (en) Drug delivery system and method of munufacturing thereof
EP2091914A4 (en) TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
PT2152195E (pt) Produto farmacêutico peptídico para distribuição oral
PL2299977T3 (pl) Liposomy do dostarczania leków i sposoby ich wytwarzania
DK2567707T3 (en) Composition of tumour-associated peptides and related anti-cancer vaccine
EP2013016B8 (en) Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
EP2162283A4 (en) SELF-BUILDING FILMS FOR PROTEIN AND DRUG DELIVERY APPLICATIONS
IL213376A0 (en) Zaleplon gastroretentive drug delivery system and uses thereof
IL199041A (en) We nanoparticle peptides and their uses
EP2400851A4 (en) COMPOSITION AND ACTIVE COMPOSITION OF BISPHOSPHONATES
PT2493474T (pt) Métodos e composições para libertação prolongada de fármacos
IL209419A0 (en) Modified drugs for use in liposomal nanoparticles
EP2164631A4 (en) MODIFICATION OF DRUG RELIEF IN SUSPENSIONS OF IONIC RESIN SYSTEMS
ZA201104497B (en) Peptide therapeutic conjugates and uses thereof
EP2413917A4 (en) DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME
IL213855A0 (en) Electronic control of drug delivery system
EP2192179A4 (en) CDH3 PEPTIDE AND MEDICINAL AGENT COMPRISING SAME
EP2247311A4 (en) COMPOSITIONS FOR RELEASING CARGO SUCH AS MEDICINES, PROTEINS AND / OR MATERIAL GENETIC SUBSTANCES
IL227737A0 (en) A substance for drug delivery capable of passing through the blood-brain barrier, and a peptide and its use
WO2008058125A3 (en) Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
PL2338473T3 (pl) Postacie farmaceutycznej dawki tizanidyny i drogi jej podawania